| Product Code: ETC7912273 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia`s import shipments of gram-positive bacterial infection products continued to show steady growth, with Lithuania, Netherlands, Switzerland, Poland, and Germany emerging as the top exporting countries. Despite the increasing CAGR of 8.51% from 2020 to 2024 and a growth rate of 7.06% from 2023 to 2024, the market remained relatively unconcentrated with a low Herfindahl-Hirschman Index (HHI). This indicates a diverse and competitive market landscape, offering opportunities for suppliers to expand their presence in the Latvian market for gram-positive bacterial infection treatments.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Gram-positive Bacterial Infections Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Gram-positive Bacterial Infections Market - Industry Life Cycle |
3.4 Latvia Gram-positive Bacterial Infections Market - Porter's Five Forces |
3.5 Latvia Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Latvia Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Latvia Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Latvia Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Gram-positive Bacterial Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gram-positive bacterial infections in Latvia |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Development of novel antibiotics and treatment options for gram-positive bacterial infections |
4.3 Market Restraints |
4.3.1 Rising antibiotic resistance among gram-positive bacteria |
4.3.2 Limited access to healthcare facilities and diagnostic tools in certain regions of Latvia |
4.3.3 Stringent regulations and guidelines for antibiotic development and usage |
5 Latvia Gram-positive Bacterial Infections Market Trends |
6 Latvia Gram-positive Bacterial Infections Market, By Types |
6.1 Latvia Gram-positive Bacterial Infections Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F |
6.1.4 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.1.5 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Gram-positive Bacterial Infections Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F |
6.2.3 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2.4 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.5 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F |
6.2.6 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F |
6.2.7 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F |
6.3 Latvia Gram-positive Bacterial Infections Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F |
6.3.3 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F |
6.4 Latvia Gram-positive Bacterial Infections Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.4.3 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.4.4 Latvia Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Gram-positive Bacterial Infections Market Import-Export Trade Statistics |
7.1 Latvia Gram-positive Bacterial Infections Market Export to Major Countries |
7.2 Latvia Gram-positive Bacterial Infections Market Imports from Major Countries |
8 Latvia Gram-positive Bacterial Infections Market Key Performance Indicators |
8.1 Percentage of patients with gram-positive bacterial infections receiving appropriate antibiotic treatment |
8.2 Rate of antibiotic resistance among gram-positive bacteria in Latvia |
8.3 Number of clinical trials for new antibiotics targeting gram-positive bacterial infections |
9 Latvia Gram-positive Bacterial Infections Market - Opportunity Assessment |
9.1 Latvia Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Latvia Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Latvia Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Latvia Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Gram-positive Bacterial Infections Market - Competitive Landscape |
10.1 Latvia Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 |
10.2 Latvia Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |